Abstract
This chapter investigates how academic KIOs can manage the boundary of regulation in bridging science to insights from humanistic disciplines. It examines (i) governance mechanisms of intellectual property policies in research consortia in which the private incentive, public responsibilities, and academic science norms coexist; (ii) factors that determine the scope of moral responsibilities that academic KIOs perceive. The internalization is a promising alliance design. The problem is to control claims of rights over inventions. The agency-based governance helps extend the trusteeship governance by unbundling property rights and ownership. By detaching and reconfiguring rights toward benefits, this direction is also consistent with the common good-based stakeholder theory. At the same time, the combination of moral identity and ownership determine the humanistic issues that KIOs perceive commitment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Argandona, A. (1998). Stakeholder theory and the common good. Journal of Business Ethics, 17, 1093–1102.
Argyris, N. S., Bercovitz, J., & Mayer, K. J. (2007). Complementarity and evolution of contract provisions: An empirical study of IT service contracts. Organizational Science, 18(1), 3–19.
Banchoff, T. (2011). Embryo politics: Ethics and policy in Atlantic democracies. Ithaca: Cornell University Press.
Banks, B., Datlow, P., Felder, A., & Wolfram, M. (2011). Dealing with joint intellectual property ownership in the US and Germany. DAJV Newsletter, 36, 58–62.
Bedlebos, R., Cassiman, B., Faems, D., Leten, B., & Looy, B. V. (2012). Co-ownership of intellectual property. Patent Statistics for Decision Making, Paris.
Bekker, R., & Updegrove, A. (2013). IPR policies and practices of a representative group of standard-setting organizations worldwide. Washington, DC: National Research Council.
Besley, T., & Ghatak, M. (2001). Government versus private ownership of public goods. The Quarterly Journal of Economics, 116(4), 1343–1372.
Buse, K., & Walt, G. (2002). The World Health Organization and global public-private health partnerships: In search of ‘good’ global health governance. In M. R. Reich (Ed.), Public-private partnerships for public health (pp. 169–195). Cambridge, USA: Harvard Center for Populations and Development Studies.
Carver, C. S., & Scheier, M. F. (1998). On the self-regulation of behavior. New York: Cambridge University Press.
Choi, C. J., Hilton, B., & Millar, C. (2004). Emerging business systems. New Hampshire and New York: Palgrave Macmillan.
Choi, C. J., & Millar, C. J. M. (2005). Knowledge entanglement. Hampshire and New York: Palgrave Macmillan.
Contreras, J. L. (2011). Bermuda’s legacy: Policy, patents, and the design of the genome commons. Minnesota Journal of Law, Science & Technology, 12(1), 61–125.
Cook-Deegan, R. (2007). The science commons in health research: Structure, function, and value. Journal of Technology Transfer, 32(3), 133–156.
Correa, C. M. (2014). Multilateral agreements and policy opportunities. In M. Cimoli, G. Dosi, K. E. Maskus, R. L. Okediji, & J. H. Reichman (Eds.), Intellectual property rights: Legal and economic challenges for development (pp. 417–433). Oxford: Oxford University Press.
Craswell, R., & Schwarts, A. (1994). Foundatoins of contract law. New York: Foundation Press.
Donaldson, T., & Dunfee, T. W. (1994). Towards a unified conception of business ethics: Integrative social contracts theory. Academy of Management Review, 19, 252–284.
Donaldson, T., & Preston, L. E. (1995). The stakeholder theory of the corporation: Concepts, evidence, and implications. Academy of Management Review, 20(1), 65–91.
Demsetz, H. (1983). The structure of ownership and the theory of the firm. Journal of Law and Economics, 26, 375–390.
Engelberg, A. B., & Kesselheim, A. S. (2016). Use the Bayh-Dole Act to lower drug prices for government healthcare programs. Nature Medicine, 22(6), 576.
European Commission. (2002). Expert group report on role and strategic use of IPR in international research collaborations (Working Paper). Brussels: EU.
Fama, E. F., & Jensen, M. C. (1983). Separation of ownership and control. Journal of Law and Economics, 26, 301–325.
Farnsworth, E. A. (1998). Farnsworth on contracts. New York: Aspen Law & Business.
Finnis, J. (1980). Natural law and natural rights. Oxford: Oxford University Press.
Fort, T. L. (2001). Ethics and governance: Business as mediating institution. New York: Oxford University Press.
Freeman, R. E., & Evan, W. M. (1990). Corporate governance: A stakeholder interpretation. The Journal of Behavioral Economics, 19(4), 337–359.
Gottweis, H., Salter, B., & Waldby, C. (2009). The global politics of human embryonic stem cell science: Regenerative medicine in transition. New Hampshire and New York: Palgrave Macmillan.
Granstrand, O. (2006). Intellectual property rights for governance in and of innovation systems. In B. Andersen (Ed.), Intellectual property rights: Innovation, governance and the institutional environment (pp. 311–343). Cheltenham and Northampton: Edward Elgar.
Greco, L. (2015). Imperfect bundling in public–private partnerships. Journal of Public Economic Theory, 17(1), 136–146.
Hannah, S. T., Avolio, B. J., & May, D. R. (2011). Moral maturation and moral conation: A capacity approach to explaining moral thought and action. Academy of Management Review, 36(4), 663–685.
Hart, O. (2003). Incomplete contracts and public ownership: Remarks, and application to public-private partnerships. The Economic Journal, 13, C69–C76.
Kivleniece, I., & Quelin, B. V. (2012). Creating and capturing value in public–private ties: A private actor’s perspective. Academy of Management Review, 37(2), 272–299.
Kunneman, H. (2010). Viable alternatives for commercialized science. In H. Radder (Ed.), The commodification of academic research (pp. 307–336). Pittsburgh: University of Pittsburg Press.
Lord, R. G., & Brown, D. J. (2004). Leadership processes and follower self-identity. Mahwah, NJ: Lawrence Erlbaum Associates.
Lucas, A. O. (2002). Public-private partnerships: Illustrative examples. In M. R. Reich, (Ed.), Public-private partnerships for public health (pp. 19–39). Cambridge, USA: Harvard Center for Population and Development Studies.
Lumineau, F., Frechet, M., & Puthod, D. (2011). An organizational learning perspective on the contracting process. Strategic Organization 9, 8–32.
Macher, J. T., Mowery, D. C., & Hodges, D. A. (1998). Reversal or fortune? The recovery of the US semiconductor industry. California Management Review, 41(1), 107–136.
Mahoney, J. T., McGahan, A. M., & Pitelis, C. N. (2009). The interdependence of private and public interests. Organization Science, 20(6), 1034–1052.
Markus, H., & Wulf, E. (1987). The dynamic self-concept: A psychological perspective. Annual Review of Psychology, 38, 299–337.
Merges, R. P., & Locke, L. A. (1990). Co-ownership of patents: A comparative and economic view. Journal of Patent and Trademark Office Society, 72, 586–599.
Merton, R. K. (1942). A note on science and democracy. Journal of Legal and Political Sociology, 1, 115–126.
Mowery, D. C. (2001). The US national innovation system after the Cold War. In P. Laredo & P. Mustar (Eds.), Research and innovation policies in the new global economy: An international comparative analysis (pp. 15–46). Cheltenham and Northampton: Edward Elgar.
Munzer, S. (1990). A theory of property. Cambridge, New York and Melbourne: Cambridge University Press.
National Cancer Institute & National Human Genome Research Institute. (2014). Revision 01-16-2014: The cancer genome atlas program: Human subjects protection and data access policies. Washington, DC.
OECD. (2011). Collaborative mechanisms for intellectual property management in the life sciences. Paris: OECD.
Okada, E. (2018). Knowledge corruption and governance in academic knowledge-intensive organizations: The case of molecular mutations research. Journal of Public Affairs, 18(1), e1698. https://doi.org/10.1002/pa.1698.
Oxford Academic Health Science Network and Structural Genomics Consortium (SGC). (2015). The intellectual property implications of open access drug discovery. Oxford.
Palfrey, Q. A. (2017). Expanding access to medicine and promoting innovation: A practical approach. Georgetown Journal on Poverty Law and Policy, 24(2), 162–197.
Rangan, S., Samii, R., & van Wassenhove, L. K. (2006). Constructive partnerships: When alliances between private firms and public actors can enable creative strategies. Academy of Management Review, 31(3), 738–751.
Rawls, J. (1993/1999). The law of peoples. In S. Freeman (Ed.), John Rawls: Collected papers (pp. 529–564). Cambridge, US: Harvard University Press.
Roberts, M. J., Breitenstein, A. G., & Roberts, C. S. (2002). The ethics of public–private partnerships. In M. R. Reich (Ed.), (pp. 67–85).
Ryckaert, V., & Van den Broeck, K. (2008). IMEC industrial affiliation program (IIAP) as IPR model to set up nanotechnology research and patenting. World Patent Information, 30, 101–105.
Schitz, P. W. (2014). Optimal ownership of public goods reconsidered. Economic Letters, 125(1), 21–22.
Sherer, P. D., & Leblebici, H. (2015). Governance in professional service firms: From structural and cultural to legal normative views. In B. Hinings, D. Muzio, J. Broschak, & L. Empson (Eds.), The oxford handbook of professional service firms (pp. 189–212). Oxford: Oxford University Press. https://doi.org/10.1093/oxfordhb/9780199682393.013.10.
So, A. D., Sampat, B. N., Rai, A. K., Cook-Deegan, R., Reichman, J. H., Weissman, R., & Kapczynski, A. (2014). Is Bayh-Dole good for developing countries? Lessons from the U.S. experience. In M. Cimoli, G. Dosi, K. E. Maskus, R. L. Okediji, & J. H. Reichman (Eds.), Intellectual property rights: Legal and economic challenges for development (pp. 202–210). Oxford: Oxford University Press.
Stigloe, J., Owen, R., & Macnaghten, P. (2013). Developing a framework for responsible innovation. Research Policy, 42, 1568–1580.
The European Patent Office’s Economic and Scientific Advisory Board (ESAB). (2015). ESAB statement on the possible introduction of a grace period in Europe. Munich: European Patent Office.
Trevino, L. K. (1982). Ethical decision making in organizations: A person-situation interactionist model. Academy of Management Review, 11(3), 601–617.
United Nations. (1948). The declaration of human rights. New York: The General Assembly of the United Nations.
Vakili, K., & McGahan, A. M. (2016). Health care’s grand challenges: Stimulating basic science on diseases that primarily afflict the poor. Academy of Management Journal, 59(6), 1917–1939.
Van den Broeck, K., & Ryckaert, V. (2006). Case study: IMEC-nanopatents. Presentation slide at IMEC patents & industry-science relations. file:///D:/REFERENCE/CHAP%207%20IP/IMEC%20IP%20POLICY%20iprworkshop_vandenbroekand_ryckaert_en.pdf.
World Health Organization. (2014). The end TB strategy. Geneva: WHO.
World Health Organization. (2015). A global action framework for TB research. Geneva: WHO Press.
World Trade Organization. (1994). Agreement on trade-related aspects of intellectual property rights, Annex IC of the Marrakesh agreement establishing the World Trade Organization.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 The Author(s)
About this chapter
Cite this chapter
Okada, E. (2019). Science and Insights from Humanistic Disciplines. In: Management of Knowledge-Intensive Organizations. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-97373-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-97373-9_7
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-319-97372-2
Online ISBN: 978-3-319-97373-9
eBook Packages: Business and ManagementBusiness and Management (R0)